Dashboard
Manage Tickers

LAB


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

standard-biotools-commences-restructuring-plan-including-15-workforce-reduction
Standard BioTools Commences Restructuring ...
09/17/2025 20:07:54

-SEC Filing

standard-biotools-affirms-fy2025-sales-guidance-of-165000m-175000m-vs-169148m-est
Standard BioTools Affirms FY2025 Sales Gui...
08/11/2025 20:41:31

Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.000 million-$175.000 million to $165.000 million-$175.000...

standard-biotools-q2-eps-from-continuing-operations-005
Standard BioTools Q2 EPS From Continuing O...
08/11/2025 20:02:35

standard-biotools-q2-eps-009-misses-008-estimate-sales-41962m-beat-39824m-estimate
Standard BioTools Q2 EPS $(0.09) Misses $(...
08/11/2025 20:02:18

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

standard-biotools-and-precise-sg100k-launch-proteomics-collaboration-with-somascan-11k-to-analyze-100000-singapore-biobank-samples
Standard BioTools And PRECISE-SG100K Launc...
08/06/2025 11:18:42

fedex-issues-soft-guidance-joins-torrid-holdings-allot-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
FedEx Issues Soft Guidance, Joins Torrid H...
06/25/2025 12:36:28

somalogic-acquisition-marks-next-step-in-illuminas-advanced-biomarker-push
SomaLogic Acquisition Marks Next Step In I...
06/23/2025 16:04:58

Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multio...

tesla-spartannash-standard-biotools-and-other-big-stocks-moving-higher-on-monday
Tesla, SpartanNash, Standard BioTools And ...
06/23/2025 15:07:56

Core News & Articles
CORRECTION: Standard BioToles Ticker Is "L...
06/23/2025 13:08:20

Core News & Articles
Standard BioTools Sells SomaLogic To Illum...
06/23/2025 11:10:06

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash  Retains Strategic...

standard-biotools-affirms-fy2025-sales-guidance-of-16500m-17500m-vs-16920m-est
Standard BioTools Affirms FY2025 Sales Gui...
05/06/2025 20:02:40

Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.00 million-$175.00 million to $165.00 million-$175.00 mil...

standard-biotools-q1-eps-007-inline-sales-4080m-beat-4010m-estimate
Standard BioTools Q1 EPS $(0.07), Inline, ...
05/06/2025 20:02:23

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

keybanc-downgrades-standard-biotools-to-sector-weight
Keybanc Downgrades Standard BioTools to Se...
02/27/2025 13:07:55

Keybanc analyst Paul Knight downgrades Standard BioTools (NASDAQ:LAB) from Overweight to Sector Weight.

standard-biotools-sees-fy2025-sales-165000m-175000m-vs-18693m-est
Standard BioTools Sees FY2025 Sales $165.0...
02/26/2025 21:11:53

Standard BioTools (NASDAQ:LAB) sees FY2025 sales of $165.000 million-$175.000 million vs $186.93 million analyst estimate.

standard-biotools-q4-eps-009-misses-007-estimate-sales-4672m-beat-4303m-estimate
Standard BioTools Q4 EPS $(0.09) Misses $(...
02/26/2025 21:11:14

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...

earnings-scheduled-for-february-26-2025
Earnings Scheduled For February 26, 2025
02/26/2025 08:32:32

intra-cellular-therapies-standard-biotools-si-bone-and-other-big-stocks-moving-higher-on-monday
Intra-Cellular Therapies, Standard BioTool...
01/13/2025 15:57:29

standard-biotools-announced-preliminary-revenue-for-q4-and-fy-2024-of-approximately-465m-and-174m-respectively-compared-to-consensus-of-4303m-and-17120m
Standard BioTools Announced Preliminary Re...
01/13/2025 12:04:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION